Cargando…

The Impact of Financial Interest in Intensity-Modulated Radiation Therapy on the Utilization of Radiation Therapy for Treatment of Newly Diagnosed Prostate Cancer: A Single Center Experience

Objective. As recent participants in an integrated prostate cancer (PCa) care center, we sought to evaluate whether financial investment in an intensity-modulated radiation therapy (IMRT) center resulted in an increased utilization of radiation therapy in our patients with newly diagnosed PCa. Mater...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiaolong S., Zola, Joseph C., McGinnis, David E., Soroush, Mehrdad, Bergmann, Leigh G., Ellis, David J., Squadrito, James F., Zeltser, Ilia S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scholarly Research Network 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3329792/ https://www.ncbi.nlm.nih.gov/pubmed/22567423 http://dx.doi.org/10.5402/2012/759258

Ejemplares similares

In silico analysis suggests differential response to bevacizumab and radiation combination therapy in newly diagnosed glioblastoma
por: Hawkins-Daarud, Andrea, et al.
Publicado: (2015)

Region of interest optimization for radiation therapy of breast cancer
por: Sauer, Tim‐Oliver, et al.
Publicado: (2021)

Improved Outcomes with Intensity Modulated Radiation Therapy Combined with Temozolomide for Newly Diagnosed Glioblastoma Multiforme
por: Aherne, Noel J., et al.
Publicado: (2014)

The prognostic value of nestin expression in newly diagnosed glioblastoma: Report from the Radiation Therapy Oncology Group
por: Chinnaiyan, Prakash, et al.
Publicado: (2008)

Cost-effectiveness of Prostate Radiation Therapy for Men With Newly Diagnosed Low-Burden Metastatic Prostate Cancer
por: Lester-Coll, Nataniel H., et al.
Publicado: (2021)

Resection and Surgically Targeted Radiation Therapy for the Treatment of Larger Recurrent or Newly Diagnosed Brain Metastasis: Results From a Prospective Trial
por: Nakaji, Peter, et al.
Publicado: (2020)

Predictors of Financial Toxicity in Patients Receiving Concurrent Radiation Therapy and Chemotherapy
por: Jiang, Julie M., et al.
Publicado: (2022)

Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma
por: Wen, Patrick Yung, et al.
Publicado: (2020)

Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study
por: Bokstein, Felix, et al.
Publicado: (2020)

MBCL-14. A STUDY OF LOW-DOSE CRANIOSPINAL RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED AVERAGE-RISK MEDULLOBLASTOMA
por: Mochizuki, Aaron, et al.
Publicado: (2020)

Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy
por: Sheu, Tommy, et al.
Publicado: (2018)

High-dose proton beam therapy versus conventional fractionated radiation therapy for newly diagnosed glioblastoma: a propensity score matching analysis
por: Matsuda, Masahide, et al.
Publicado: (2023)

The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme
por: Lai, Rose, et al.
Publicado: (2010)

Evidence-based region of interest matching guidelines for sarcoma volumetric image-guided radiation therapy()
por: Li, Winnie, et al.
Publicado: (2018)

Financial Toxicity as an End Point in Prospective Clinical Trials Involving Radiation Therapy
por: Prasad, Rahul N., et al.
Publicado: (2022)

Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab
por: Wen, Qiuting, et al.
Publicado: (2014)

Diabetic Retinopathy: Animal Models, Therapies, and Perspectives
por: Cai, Xue, et al.
Publicado: (2016)

Clinical and Radiographic Presentations of COVID-19 Among Patients Receiving Radiation Therapy for Thoracic Malignancies
por: Samson, Pamela, et al.
Publicado: (2020)

Therapy of newly diagnosed follicular lymphoma
por: Westin, Jason R., et al.
Publicado: (2012)

Financial Counseling Is Associated with Reduced Financial Difficulty Scores in Head and Neck Cancer Patients Treated with Radiation Therapy
por: Farrugia, Mark, et al.
Publicado: (2021)

Neuroinflammatory and cognitive consequences of combined radiation and immunotherapy in a novel preclinical model
por: McGinnis, Gwendolyn J., et al.
Publicado: (2016)

The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
por: Gaspar, Laurie E., et al.
Publicado: (2009)

A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
por: Rosenfeld, Myrna R, et al.
Publicado: (2014)

Three Cases of Levodopa-Resistant Parkinsonism After Radiation Therapy
por: Mehanna, Raja, et al.
Publicado: (2016)

Interstitial photodynamic therapy for newly diagnosed glioblastoma
por: Quach, Stefanie, et al.
Publicado: (2023)

CNS side effects of immune checkpoint inhibitors: preclinical models, genetics and multimodality therapy
por: McGinnis, Gwendolyn J, et al.
Publicado: (2017)

Radiation therapy staffing model 2014
por: Smith, Leigh J., et al.
Publicado: (2016)

Radiation Dose to the Rectum With Definitive Radiation Therapy and Hydrogel Spacer Versus Postprostatectomy Radiation Therapy
por: Yang, Daniel X., et al.
Publicado: (2020)

Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era
por: Paravati, Anthony J., et al.
Publicado: (2010)

Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study
por: Navarria, Pierina, et al.
Publicado: (2017)

A Randomized Study of Short Course (One Week) Radiation Therapy with or without Temozolomide in Elderly and/or Frail Patients with Newly Diagnosed Glioblastoma (GBM)
por: Thakur, Subhash, et al.
Publicado: (2022)

SPCR-03 NEUROCOGNITIVE OUTCOMES FROM PHASE 1 TRIAL OF BMX-001 IN COMBINATION WITH CONCURRENT RADIATION THERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED HIGH-GRADE GLIOMA PATIENTS
por: Peters, Katherine, et al.
Publicado: (2022)

Conformal Radiation Therapy or Stereotactic Body Radiation Therapy: Institutional Experience in the Management of Colorectal Liver Metastases by Radiation Therapy
por: He, Zemin, et al.
Publicado: (2018)

Scalp-Sparing Radiation With Concurrent Temozolomide and Tumor Treating Fields (SPARE) for Patients With Newly Diagnosed Glioblastoma
por: Miller, Ryan, et al.
Publicado: (2022)

Patient-Reported Financial Burden Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer
por: Sholklapper, Tamir N., et al.
Publicado: (2022)

Radiation Therapy After Radical Prostatectomy
por: Ziada, Ali M., et al.
Publicado: (2004)

Changing the global radiation therapy paradigm
por: Pistenmaa, David A, et al.
Publicado: (2018)

Developing a Pipeline for Multiparametric MRI-Guided Radiation Therapy: Initial Results from a Phase II Clinical Trial in Newly Diagnosed Glioblastoma
por: Kim, Michelle M., et al.
Publicado: (2019)

Irradiation-induced nasopharyngeal necrosis (INN) in newly diagnosed nasopharyngeal carcinoma treated by intensity-modulated radiation therapy: clinical characteristics and the influence of treatment strategies
por: Xu, Yi, et al.
Publicado: (2022)

Radiation therapy physics
por: Smith, Alfred R
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_iingr20ov9nf2ni2b93al5gojt